Navigation Links
DATATRAK Academy Expands to Include Durham Technical Community College
Date:5/10/2011

CLEVELAND, May 10, 2011 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announces the expansion of its DATATRAK Academy to include an agreement with Durham Technical Community College (DTCC) to license its DATATRAK eClinical® software suite. DTCC students and employees will use the eClinical software in its Clinical Trials Research program and courses. The software is used as part of the Clinical Trials Research Associate curriculum, which prepares individuals to assist investigators and clinical researchers in clinical research studies for the development of new drugs, clinical products, and treatment regimens.

"The DATATRAK Academy provides hands-on experience with the multitude of opportunities in the clinical research industry. It is a great method for recruiting the brightest, most innovative minds into our company, while at the same time, strengthening the bonds with our local communities and educating people on the importance of clinical trial research," stated Laurence P. Birch, DATATRAK's Chairman of the Board and CEO. "Expanding the Academy to include DTCC, allows its graduates to enter the field with prior electronic data capture experience. Not only are the program's graduates more marketable, but the industry benefits by having knowledgeable research associates to manage clinical trials."

DATATRAK Academy is an outreach program that furthers DATATRAK's vision of being the clinical enterprise solution to safely accelerate every drug, every biologic and every device from concept to cure. DATATRAK offers a unique program in conjunction with local academic institutions to provide hands-on experience in the clinical trials space; from software development to end-user training, the DATATRAK Academy advances the education of future healthcare industry participants.

About Durham Technical Community College

For nearly 50 years, Durham Technical Community College has provided high-quality, affordable, and convenient technical and career education; served as the springboard to a bachelor's degree; enabled tens of thousands of Triangle residents to enjoy continuing education offerings; and given many thousands more a second chance at success through adult literacy programs.  For more information on DTCC's Clinical Trials Research Associate degree, please see http://www.durhamtech.edu/programs/clintrials.htm.

About DATATRAK International, Inc.

DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK eClinical® unified software suite, deployed worldwide through an ASP or Enterprise Transfer offering, has successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 67 countries. DATATRAK has offices located in Cleveland, Ohio, and Bryan, Texas. For more information, visit http://www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 25, 2011 announcing its fourth quarter and full year results for 2010. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE DATATRAK International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. DATATRAK International, Inc. Announces Initial Equity Research Coverage by Zacks Investment Research
2. DAIICHI SANKYO EUROPE GmbH Selects DATATRAK eClinicalâ„¢ for Pan-European Systolic Hypertension Study
3. DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management
4. DATATRAK Exhibiting at the DIAs 46th Annual Meeting
5. DATATRAK Signs New Client for Rescue Study
6. DATATRAK International, Inc. to Release 2009 Second Quarter and First-Half Operating Results on August 17, 2009
7. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
8. At This Years American Academy of AntiAging (A4M) Conference, Glycation and AGEs (Advanced Glycation End Products) Were Named the Leading Factors in Premature Aging and Disease
9. VentiRx Pharmaceuticals Presents Positive Clinical and Pre-Clinical Data at American Academy of Allergy Asthma & Immunology Annual Meeting
10. MiMedx to Attend American Academy of Orthopedic Surgeons Annual Meeting
11. Renhuang Receives AAA(1) Rating from Chinese Academy of International Trade & Economic Cooperation of Ministry of Commerce
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
(Date:6/23/2016)... PUNE, India , June 23, 2016 /PRNewswire/ ... culture media market research report to its pharmaceuticals ... company profiles, product details and much more. ... market spread across 151 pages, profiling 15 companies ... now available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/2/2016)... 2, 2016 Perimeter Surveillance & ... Systems, Physical Infrastructure, Support & Other Service  ... offers comprehensive analysis of the global Border ... generate revenues of $17.98 billion in 2016. ... a leader in software and hardware technologies for advanced ...
Breaking Biology News(10 mins):